These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 35971323)

  • 1. Current status and challenges of drug development for hormonal treatment of endometriosis: a systematic review of randomized control trials.
    Zajec V; Mikuš M; Vitale SG; D'alterio MN; Gregov M; Šarić MJ; Carugno J; Angioni S; Ćorić M
    Gynecol Endocrinol; 2022 Sep; 38(9):713-720. PubMed ID: 35971323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. State of the art, new treatment strategies, and emerging drugs for non-hormonal treatment of endometriosis: a systematic review of randomized control trials.
    Mikuš M; Vitale SG; Ćorić M; Zajec V; Ciebiera M; Carugno J; D'alterio MN; Herman M; Puževski T; Angioni S
    Gynecol Endocrinol; 2022 Nov; 38(11):911-917. PubMed ID: 36237165
    [No Abstract]   [Full Text] [Related]  

  • 3. Novel pharmacological therapies for the treatment of endometriosis.
    Buggio L; Dridi D; Barbara G; Merli CEM; Cetera GE; Vercellini P
    Expert Rev Clin Pharmacol; 2022 Sep; 15(9):1039-1052. PubMed ID: 36000243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of oral gonadotropin-releasing hormone antagonists in moderate-to-severe endometriosis-associated pain: a systematic review and network meta-analysis.
    Xin L; Ma Y; Ye M; Chen L; Liu F; Hou Q
    Arch Gynecol Obstet; 2023 Oct; 308(4):1047-1056. PubMed ID: 36656435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral gonadotropin-releasing hormone antagonists for treating endometriosis-associated pain: a systematic review and network meta-analysis.
    Yan H; Shi J; Li X; Dai Y; Wu Y; Zhang J; Gu Z; Zhang C; Leng J
    Fertil Steril; 2022 Dec; 118(6):1102-1116. PubMed ID: 36283862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From pathogenesis to clinical practice: Emerging medical treatments for endometriosis.
    Clemenza S; Sorbi F; Noci I; Capezzuoli T; Turrini I; Carriero C; Buffi N; Fambrini M; Petraglia F
    Best Pract Res Clin Obstet Gynaecol; 2018 Aug; 51():92-101. PubMed ID: 29559388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical therapy options for endometriosis related pain, which is better? A systematic review and network meta-analysis of randomized controlled trials.
    Samy A; Taher A; Sileem SA; Abdelhakim AM; Fathi M; Haggag H; Ashour K; Ahmed SA; Shareef MA; AlAmodi AA; Keshta NHA; Shatat HBAE; Salah DM; Ali AS; El Kattan EAM; Elsherbini M
    J Gynecol Obstet Hum Reprod; 2021 Jan; 50(1):101798. PubMed ID: 32479894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New medical treatments for painful endometriosis: CNGOF-HAS Endometriosis Guidelines].
    Legendre G; Delbos L; Hudon E; Chabbert-Buffet N; Geoffron S; Sauvan M; Fernandez H; Bouet PE; Descamps P
    Gynecol Obstet Fertil Senol; 2018 Mar; 46(3):256-263. PubMed ID: 29530558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist.
    Taylor HS; Giudice LC; Lessey BA; Abrao MS; Kotarski J; Archer DF; Diamond MP; Surrey E; Johnson NP; Watts NB; Gallagher JC; Simon JA; Carr BR; Dmowski WP; Leyland N; Rowan JP; Duan WR; Ng J; Schwefel B; Thomas JW; Jain RI; Chwalisz K
    N Engl J Med; 2017 Jul; 377(1):28-40. PubMed ID: 28525302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linzagolix: a new GnRH-antagonist under investigation for the treatment of endometriosis and uterine myomas.
    Dababou S; Garzon S; Laganà AS; Ferrero S; Evangelisti G; Noventa M; D'Alterio MN; Palomba S; Uccella S; Franchi M; Barra F
    Expert Opin Investig Drugs; 2021 Sep; 30(9):903-911. PubMed ID: 34278887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of endometriosis-associated pain with linzagolix, an oral gonadotropin-releasing hormone-antagonist: a randomized clinical trial.
    Donnez J; Taylor HS; Taylor RN; Akin MD; Tatarchuk TF; Wilk K; Gotteland JP; Lecomte V; Bestel E
    Fertil Steril; 2020 Jul; 114(1):44-55. PubMed ID: 32505383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elagolix for endometriosis: all that glitters is not gold.
    Vercellini P; Viganò P; Barbara G; Buggio L; Somigliana E;
    Hum Reprod; 2019 Feb; 34(2):193-199. PubMed ID: 30551159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comprehensive review of hormonal and biological therapies for endometriosis: latest developments.
    Barra F; Grandi G; Tantari M; Scala C; Facchinetti F; Ferrero S
    Expert Opin Biol Ther; 2019 Apr; 19(4):343-360. PubMed ID: 30763525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of aromatase inhibitors to treat endometriosis-related pain symptoms: a systematic review.
    Ferrero S; Gillott DJ; Venturini PL; Remorgida V
    Reprod Biol Endocrinol; 2011 Jun; 9():89. PubMed ID: 21693038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormonal therapy for endometriosis: from molecular research to bedside.
    Tosti C; Biscione A; Morgante G; Bifulco G; Luisi S; Petraglia F
    Eur J Obstet Gynecol Reprod Biol; 2017 Feb; 209():61-66. PubMed ID: 27503693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A peek into the drug development scenario of endometriosis - A systematic review.
    Goenka L; George M; Sen M
    Biomed Pharmacother; 2017 Jun; 90():575-585. PubMed ID: 28407578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre- and postsurgical medical therapy for endometriosis surgery.
    Chen I; Veth VB; Choudhry AJ; Murji A; Zakhari A; Black AY; Agarpao C; Maas JW
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD003678. PubMed ID: 33206374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical Management of Endometriosis in Patients with Chronic Pelvic Pain.
    Bedaiwy MA; Allaire C; Yong P; Alfaraj S
    Semin Reprod Med; 2017 Jan; 35(1):38-53. PubMed ID: 28002850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic review of the effects of aromatase inhibitors on pain associated with endometriosis.
    Nawathe A; Patwardhan S; Yates D; Harrison GR; Khan KS
    BJOG; 2008 Jun; 115(7):818-22. PubMed ID: 18485158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of eliapixant in endometriosis-associated pelvic pain: the randomized, placebo-controlled phase 2b SCHUMANN study.
    Parke S; Gude K; Roth K; Messina F
    BMC Womens Health; 2024 Jun; 24(1):353. PubMed ID: 38890641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.